Each year, the US Food and Drug Administration (FDA) approves far fewer health technologies for use in children than adults. This means that pediatric specialists do not always have access to the advanced tools they need to address the unique healthcare needs of their small, vulnerable patients.
Stanford launched Impact1 to improve the health, safety, and quality of life of pediatric patients and pregnant women. We do this by accelerating the development and availability of high-value, high-impact pediatric health technologies.
The program leverages Stanford Biodesign’s need-driven innovation process to accomplish this goal. It benefits from access to world-renowned clinicians and engineers at Stanford, as well as an unparalleled network of Silicon Valley experts in medical device product development, regulatory affairs, intellectual property, reimbursement, and commercialization.
Our team also represents the Stanford collaborators of the UCSF-Stanford Pediatric Device Consortium.
Company Details
- Employees
- 9
- Address
- Stanford, Us
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Keywords
- New York.
- HQ
- Stanford
- Competitors
- Stanford Biodesign Alumni Association, Stanford Mussallem Center for Biodesign, Midwest Pediatric Device Consortium, Rhaeos, Fogarty Innovation, Deerfield Management, Starlight Cardiovascular, i4KIDS I i4KIDS-EUROPE, CobiCure, SWPDC - Southwest National Pediatric Device Innovation Consortium.
Impact1 At Stanford Biodesign Questions
Impact1 At Stanford Biodesign's website is https://biodesign.stanford.edu/programs/impact1.html
Impact1 At Stanford Biodesign's LinkedIn profile is https://www.linkedin.com/company/impact1biodesign
Impact1 At Stanford Biodesign has
9 employees.
View email and phone details for 9
employees at Impact1 At Stanford Biodesign.
Impact1 At Stanford Biodesign's industry is
Hospitals and Health Care
Impact1 At Stanford Biodesign's top competitors are
Stanford Biodesign Alumni Association,
Stanford Mussallem Center For Biodesign,
Midwest Pediatric Device Consortium,
Rhaeos,
Fogarty Innovation,
Deerfield Management,
Starlight Cardiovascular,
I4kids I I4kids-Europe,
Cobicure,
Swpdc - Southwest National Pediatric Device Innovation Consortium.
Impact1 At Stanford Biodesign's categories are Hospitals and Health Care
